Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Shade

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Contemporary Clinical Trials|April 8, 2015
Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationaleKathryn Blake, Janet T Holbrook, Holly Antal, et al.
Pediatric Pulmonology|November 13, 2012
Obesity in children with poorly controlled asthma: Sex differencesJason E Lang, Janet T Holbrook, Robert A Wise, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Biologic mechanisms of environmental tobacco smoke in children with poorly controlled asthma: results from a multicenter clinical trialJason E Lang, Allen J Dozor, Janet T Holbrook, et al.
JMIR Pediatrics and Parenting|June 22, 2023
Comprehension by Caregivers and Adolescents of Clinical Trial Information Delivered via Multimedia Video Versus Conventional Practice: Nonrandomized Controlled TrialKathryn V Blake, Holly Antal, H Timothy Bunnell, et al.
Alzheimer'S Research & Therapy|May 24, 2026
Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trialMyuri Ruthirakuhan, Maya Mills, Paul Rosenberg, et al.
International Psychogeriatrics|September 19, 2024
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2Shankar Tumati, Nathan Herrmann, Jaime Perin, et al.
International Psychogeriatrics|January 31, 2025
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2Shankar Tumati, Nathan Herrmann, Jaime Perin, et al.
JAMA Neurology|September 27, 2021
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical TrialJacobo Mintzer, Krista L Lanctôt, Roberta W Scherer, et al.
International Journal of Geriatric Psychiatry|June 10, 2024
Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)Lijuan Zeng, Jamie Perin, Alden L Gross, et al.
International Psychogeriatrics|March 14, 2025
Correlation between changes in apathy and cognition in Alzheimer's disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)Krushnaa Sankhe, Shankar Tumati, Jamie Perin, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Contemporary Clinical Trials|April 8, 2015
Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationaleKathryn Blake, Janet T Holbrook, Holly Antal, et al.
Pediatric Pulmonology|November 13, 2012
Obesity in children with poorly controlled asthma: Sex differencesJason E Lang, Janet T Holbrook, Robert A Wise, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Biologic mechanisms of environmental tobacco smoke in children with poorly controlled asthma: results from a multicenter clinical trialJason E Lang, Allen J Dozor, Janet T Holbrook, et al.
JMIR Pediatrics and Parenting|June 22, 2023
Comprehension by Caregivers and Adolescents of Clinical Trial Information Delivered via Multimedia Video Versus Conventional Practice: Nonrandomized Controlled TrialKathryn V Blake, Holly Antal, H Timothy Bunnell, et al.
Alzheimer'S Research & Therapy|May 24, 2026
Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trialMyuri Ruthirakuhan, Maya Mills, Paul Rosenberg, et al.
International Psychogeriatrics|September 19, 2024
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2Shankar Tumati, Nathan Herrmann, Jaime Perin, et al.
International Psychogeriatrics|January 31, 2025
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2Shankar Tumati, Nathan Herrmann, Jaime Perin, et al.
JAMA Neurology|September 27, 2021
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical TrialJacobo Mintzer, Krista L Lanctôt, Roberta W Scherer, et al.
International Journal of Geriatric Psychiatry|June 10, 2024
Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)Lijuan Zeng, Jamie Perin, Alden L Gross, et al.
International Psychogeriatrics|March 14, 2025
Correlation between changes in apathy and cognition in Alzheimer's disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)Krushnaa Sankhe, Shankar Tumati, Jamie Perin, et al.
Pageof 4